Axim Biotechnologies 2022 Winter Company Presentation

Axim Biotechnologies is developing innovative point-of-care diagnostic solutions focused on COVID-19 neutralizing antibody testing, cancer biomarker detection, and ocular disorder diagnostics. The company is pioneering the first rapid diagnostic test measuring functional neutralizing antibodies and partnering with institutions like Mayo Clinic and Arizona State University to advance its diagnostic portfolio.